Evaluation of Parkinson's disease (PD) prevalence in patients with malignant melanoma (MM)

被引：0
|
作者：
Rigel, DS
Patel, Z
Bolognia, J
Eichler, C
Ellis, DL
Friedman, RJ
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [21] Dysautonomy in patients with Parkinson's disease (PD)
    Vasilenko, A. F.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S327 - S327
  • [22] The relationship of Parkinson's disease (PD) and melanoma: An epidemiological survey in Israel
    Inzelberg, R.
    Rabey, J. M.
    Djaldetti, R.
    Reches, A.
    Badarny, S.
    Hassin-Baer, S.
    Trau, H.
    Aharon-Peretz, J.
    Huberman, M.
    Gilead, L.
    Giladi, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 12 - 12
  • [23] Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
    Matsuo, Yasuhiro
    Kamitani, Tetsu
    [J]. PLOS ONE, 2010, 5 (05):
  • [24] Prevalence of Fatigue in Parkinson's Disease Patients
    Nassif, Daniel
    Pereira, Joao
    [J]. MOVEMENT DISORDERS, 2018, 33 : S102 - S102
  • [25] Prevalence of depression in Parkinson's disease patients
    Weldehana, A. M.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S492 - S493
  • [26] Periodontal Health and Caries Prevalence Evaluation in Patients Affected by Parkinson's Disease
    Cicciu, Marco
    Risitano, Giacomo
    Lo Giudice, Giuseppe
    Bramanti, Ennio
    [J]. PARKINSONS DISEASE, 2012, 2012
  • [27] THE PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH PARKINSON'S DISEASE
    Doherty, J. G.
    Jan, A. K.
    Rooney, B.
    Hickey, P. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 52 - 52
  • [28] Results of the PRAMI study: Prevalence of neuropsychiatric symptoms in patients with idiopathic Parkinson's disease (PD)
    Dujardin, M.
    Lleu, P. L.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S243 - S243
  • [29] Parkinson's disease and melanoma: a serie of 33 patients
    Doridam, J.
    Nader, M.
    Melin, A.
    Avril, M. F.
    Maubec, E.
    Degos, B.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S338 - S338
  • [30] Pergolide pharmacokinetics in patients with Parkinson's disease (PD)
    Thalamas, C.
    Rajman, I.
    Bareille, M. P.
    Mackie, A.
    Soubrouillard, C.
    Kulisevsky, J.
    Descombes, S.
    Brefel-Courbon, C.
    Fabre, N.
    Barbanoj, M. J.
    Blin, O.
    Rascol, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 115 - 115
12345